Ftse Mib
34.226,60
-0,05%
DAX
18.495,66
0,31%
S&P 500
5.187,70
0,13%
NASDAQ
16.332,56
-0,10%
Bitcoin
62.196,74
-0,22%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Chinook Therapeutics Inc (KDNY) Chinook Therapeutics Inc (KDNY) Notizie

KDNY

Chinook Therapeutics (KDNY)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:KDNY
DataOraFonteTitoloSimboloCompagnia
22/11/202322:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:KDNYChinook Therapeutics Inc
21/08/202319:21Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:KDNYChinook Therapeutics Inc
17/08/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:KDNYChinook Therapeutics Inc
11/08/202323:02Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:KDNYChinook Therapeutics Inc
11/08/202322:39Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:KDNYChinook Therapeutics Inc
11/08/202322:35Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:KDNYChinook Therapeutics Inc
11/08/202322:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KDNYChinook Therapeutics Inc
11/08/202322:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KDNYChinook Therapeutics Inc
07/08/202322:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KDNYChinook Therapeutics Inc
01/08/202313:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KDNYChinook Therapeutics Inc
28/07/202314:00GlobeNewswire Inc.Chinook Therapeutics Announces First Patient Enrolled in Pivotal Phase 3 BEYOND Study of Zigakibart (BION-1301) for Patients with IgA NephropathyNASDAQ:KDNYChinook Therapeutics Inc
10/07/202322:01Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:KDNYChinook Therapeutics Inc
20/06/202315:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:KDNYChinook Therapeutics Inc
20/06/202315:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KDNYChinook Therapeutics Inc
17/06/202313:15GlobeNewswire Inc.Chinook Therapeutics Presents Data from CHK-336 Phase 1 Trial in Healthy Volunteers and New Insights into the Role of Failed Repair in Chronic Kidney Disease at the 60th European Renal Association (ERA) CongressNASDAQ:KDNYChinook Therapeutics Inc
12/06/202322:00GlobeNewswire Inc.Chinook Therapeutics to Present Updated Data from Zigakibart (BION-1301) Phase 1/2 Trial in Patients with IgA Nephropathy (IgAN) at the 60th European Renal Association (ERA) CongressNASDAQ:KDNYChinook Therapeutics Inc
12/06/202316:40Dow Jones NewsTrending: Novartis Buying Chinook Therapeutics for Up to $3.5 BillionNASDAQ:KDNYChinook Therapeutics Inc
12/06/202315:42Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:KDNYChinook Therapeutics Inc
12/06/202314:09Dow Jones NewsFlurry of European Companies Engaged in Acquisitions, Asset Sales Monday -- at a GlanceNASDAQ:KDNYChinook Therapeutics Inc
12/06/202307:53Dow Jones NewsNovartis to Acquire Chinook Therapeutics for Up to $3.5 BillionNASDAQ:KDNYChinook Therapeutics Inc
12/06/202307:00GlobeNewswire Inc.Chinook Therapeutics Enters into Agreement to be Acquired by Novartis AGNASDAQ:KDNYChinook Therapeutics Inc
01/06/202301:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KDNYChinook Therapeutics Inc
16/05/202314:00GlobeNewswire Inc.Chinook Therapeutics Announces Partnership with Ionis to Develop Antisense Therapy for Rare, Severe Chronic Kidney DiseaseNASDAQ:KDNYChinook Therapeutics Inc
09/05/202322:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KDNYChinook Therapeutics Inc
09/05/202322:00GlobeNewswire Inc.Chinook Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate UpdatesNASDAQ:KDNYChinook Therapeutics Inc
05/05/202322:05GlobeNewswire Inc.Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KDNYChinook Therapeutics Inc
05/05/202322:00GlobeNewswire Inc.Chinook Therapeutics Announces Upcoming Presentations and Investor Conference Call at the 60th European Renal Association (ERA) CongressNASDAQ:KDNYChinook Therapeutics Inc
28/04/202323:43Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:KDNYChinook Therapeutics Inc
27/04/202322:00GlobeNewswire Inc.Chinook Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:KDNYChinook Therapeutics Inc
17/04/202322:52Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:KDNYChinook Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:KDNY

La tua Cronologia

BIT
UCG
Unicredit
BIT
RACE
Ferrari NV
BIT
STLAM
Stellantis NV
BIT
BAMI
Banco BPM
BIT
LDO
Leonardo
BIT
ISP
Intesa Sanpaolo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
CPR
Davide Campari
BIT
BPE
Bper Banca
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
MAIRE
Maire Tecnimont
BIT
STMMI
ST Microelectronics
BIT
FBK
Finecobank
BIT
BPSO
Banca Popolare di Sondrio
BIT
G
Generali
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network